Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.96 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.96 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.96 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.96 |
| ▸ | APAF1 | O14727 | 1/20 | 0.96 |
| ▸ | NPC1 | O15118 | 1/20 | 0.96 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.96 |
| ▸ | MAPT | P10636 | 1/20 | 0.96 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.96 |
| ▸ | HTT | P42858 | 1/20 | 0.96 |
| ▸ | RAB9A | P51151 | 1/20 | 0.96 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.96 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.96 |
| ▸ | FDPS | P14324 | 16/20 | 0.44 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL372300 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL34918 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL92681 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL4061743 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL2219975 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL413428 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL4066192 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL15535406 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL2890408 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 | |
| SCHEMBL5305358 | 1.00 | MEN1 (0.96) | MEN1HSP90AA1KMT2ASMN1; SMN2APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4650498-A1 | FLUID CONTACTING DEVICE | Aurotec GmbH (AT) | 2025-11-19 | — | — | EP | claimed |
| WO-2024078801-A1 | CURABLE AND ELECTRICALLY DEBONDABLE ONE-COMPONENT (1K) STRUCTURAL ADHESIVE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2024-04-18 | — | — | WO | claimed |
| EP-4353760-A1 | CURABLE AND ELECTRICALLY DEBONDABLE ONE-COMPONENT (1K) STRUCTURAL ADHESIVE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2024-04-17 | — | — | EP | claimed |
| CN-115141480-A | Antistatic thermoplastic polyurethane and preparation method and application thereof | 上海朗亿功能材料有限公司 | 2022-10-04 | — | — | CN | claimed |
| US-11377535-B2 | Carbon fiber recovery compositions and methods | THE BOEING COMPANY (US) | 2022-07-05 | — | — | US | claimed |
| US-20200207940-A1 | Carbon Fiber Recovery Compositions and Methods | THE BOEING COMPANY | 2020-07-02 | — | — | US | claimed |
| US-10611892-B2 | Carbon fiber recovery compositions and methods | THE BOEING COMPANY (US) | 2020-04-07 | — | — | US | claimed |
| US-20180291174-A1 | Carbon Fiber Recovery Compositions and Methods | THE BOEING COMPANY | 2018-10-11 | — | — | US | claimed |
| US-9839591-B2 | Anionic dye or brightener bearing an ammonium or phosphonium counterion, dye composition comprising them and process for dyeing keratin fibres using these dyes | L'OREAL (FR) | 2017-12-12 | — | — | US | claimed |
| EP-3095804-B1 | CURING COMPOSITIONS | AQDOT LTD (GB) | 2017-09-27 | — | — | EP | claimed |
| US-8829201-B2 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2014-09-09 | — | — | US | claimed |
| WO-2013079514-A1 | SULPHUR-FREE TRANSITION METAL-ISOCYANATE-BASED IONIC LIQUIDS | UNIVERSITÄT ROSTOCK (DE) | 2013-06-06 | — | — | WO | claimed |
| US-20120318360-A1 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2012-12-20 | — | — | US | claimed |
| EP-1362572-B2 | Use of at least one particular organic salt for cleansing and/or conditioning keratinous materials, use of a particular organic salt as conditioning agent for said materials and process for cosmetic treatment | OREAL (FR) | 2011-08-17 | — | — | EP | claimed |
| US-7858802-B2 | Method of preparing ionic liquids | BASF SE (DE) | 2010-12-28 | — | — | US | claimed |
| US-7847130-B2 | Ionic additive for catalysis in biphasic reaction systems | THE UNIVERSITY COURT OF THE UNIVERSITY OF ST. ANDREWS (GB) | 2010-12-07 | — | — | US | claimed |
| US-20090318734-A1 | IONIC ADDITIVE FOR CATALYSIS IN BIPHASIC REACTION SYSTEMS | THE UNIVERSITY COURT OF THE UNIVERSITY OF ST. ANDREWS (GB) | 2009-12-24 | — | — | US | claimed |
| EP-1362572-B1 | Use of at least one particular organic salt for cleansing and/or conditioning keratinous materials, use of a particular organic salt as conditioning agent for said materials and process for cosmetic treatment | OREAL (FR) | 2008-04-16 | — | — | EP | claimed |
| EP-1649894-A2 | Composition comprising electrophilic monomers and organic salts, use for treatment of keratinic materials | L'OREAL (FR) | 2006-04-26 | — | — | EP | claimed |
| EP-1362572-A1 | Cosmetic composition comprising at least one particular organic salt and its use for cleansing and/or conditioning keratinous materials, use of a particular organic salt as conditioning agent for said materials and process for cosmetic treatment | L'OREAL (FR) | 2003-11-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120318360-A1 | Electrolyte Formulations | NHERF1, HCN4, DDT | MEN1 1923/4885HSP90AA1 4529/4885KMT2A 2453/4885 |
| US-20090318734-A1 | IONIC ADDITIVE FOR CATALYSIS IN BIPHASIC REACTION SYSTEMS | WEE2, WEE1, ITK | MEN1 3807/4885HSP90AA1 3296/4885KMT2A 837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.